Based in Miami, Hello™, a pioneer in bespoke health and wellness solutions, is thrilled to share news of its successful £4 million self-financed pre-seed funding round. This noteworthy financial achievement highlights the firm’s dedication to transforming the wellness and weight loss sector through cutting-edge GLP-1 medication treatments and an AI-powered platform.
Armed with this significant investment, Hello™ is poised to reshape the weight management industry. The enterprise’s innovative strategy merges the latest medical research with custom lifestyle modifications, crafting a personalised wellness journey for each client.
“Our mission statement at Hello™ is to redefine what it means to achieve wellness and weight loss. The confidence shown by our investors enables us to accelerate our mission, enhancing our capabilities to deliver personalized, effective, and science-backed weight loss solutions. We’re not just creating a product; we’re creating a movement towards a healthier future for everyone.”
The funding will be channelled into refining Hello’s bespoke technology, enlarging its specialist team, and broadening its reach to those on a quest for a scientifically supported, personalised weight loss experience. Hello™ is committed to offering more than mere weight loss remedies; it seeks to instigate a comprehensive lifestyle transformation.
During its invitation-only phase, Hello™ has already proven the efficacy of its regimen, with thousands of American clients achieving substantial, enduring weight reduction. With the public debut, the organisation is set to broaden its impact, introducing its trailblazing wellness and weight loss methodology to a larger audience across the nation.
